KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cardlytics (CDLX) EBT Margin (2017 - 2026)

Cardlytics filings provide 10 years of EBT Margin readings, the most recent being 40.21% for Q1 2026.

  • Quarterly EBT Margin fell 2192.0% to 40.21% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 50.56% through Mar 2026, up 1508.0% year-over-year, with the annual reading at 44.36% for FY2025, 2366.0% up from the prior year.
  • EBT Margin hit 40.21% in Q1 2026 for Cardlytics, down from 14.71% in the prior quarter.
  • Across five years, EBT Margin topped out at 48.64% in Q1 2022 and bottomed at 458.5% in Q4 2022.
  • Average EBT Margin over 5 years is 72.39%, with a median of 30.33% recorded in 2023.
  • The largest annual shift saw EBT Margin tumbled -43663bps in 2022 before it skyrocketed 34542bps in 2023.
  • Cardlytics' EBT Margin stood at 458.5% in 2022, then soared by 75bps to 113.09% in 2023, then surged by 81bps to 21.07% in 2024, then skyrocketed by 30bps to 14.71% in 2025, then plummeted by -173bps to 40.21% in 2026.
  • Per Business Quant, the three most recent readings for CDLX's EBT Margin are 40.21% (Q1 2026), 14.71% (Q4 2025), and 139.67% (Q3 2025).